Mental Health

Invega Hafyera, an antipsychotic medication, carries a notable boxed warning issued by the Food and Drug Administration (FDA). This significant alert indicates potential dangers associated with the drug, particularly for vulnerable populations. Specifically, it raises concerns for adults aged 65 and older suffering from dementia-related psychosis. Older adults in this category face an elevated risk
0 Comments
The use of any medication during pregnancy is a critical area of concern, particularly when it comes to drugs like divalproex sodium. This antiepileptic medication poses significant risks that necessitate careful consideration for anyone who may become pregnant. Understanding the implications of using divalproex sodium involves delving into its potential effects on fetal development, the
0 Comments
In the complex arena of psychological treatment, Problem-Solving Therapy (PST) emerges as a powerful tool that enables individuals to confront the stresses of daily life by systematically breaking down their challenges. This therapeutic approach not only demystifies overwhelming circumstances but also provides practical, actionable strategies that foster resilience and self-efficacy among users. Although PST is
0 Comments
Invega Sustenna, a long-acting injectable medication primarily used for treating schizophrenia and schizoaffective disorder, is gaining traction in mental health treatment due to its extended release formulation. Unlike traditional oral medications that require daily dosing, Invega Sustenna is administered once a month, providing convenience and adherence for patients. However, like all medications, it comes with
0 Comments
Attention Deficit Hyperactivity Disorder (ADHD) is a complex neurodevelopmental disorder recognized in various forms. The diagnostic criteria established by the Diagnostic and Statistical Manual of Mental Disorders, 5th edition, text revision (DSM-5-TR), delineate three primary types: predominantly inattentive, predominantly hyperactive-impulsive, and combined presentation. Despite this classification, some practitioners argue for additional subtypes, aiming to better
0 Comments
In recent years, the conversation around mental health has gained significant traction, yet disparities persist, particularly among racial and ethnic minorities. This article examines the complexities involved in mental health treatment, the cultural influences that shape access and experience, and the systemic barriers that hinder equitable care for all individuals, regardless of their background. Understanding
0 Comments
In today’s increasingly diverse society, the challenges faced by multiracial individuals are gaining attention as a significant area of concern within mental health discourse. Research has shown that individuals with mixed racial backgrounds often experience heightened vulnerability to mental health issues, including depression, anxiety, and substance use disorders. A central contributor to these challenges is
0 Comments
Vraylar, known generically as cariprazine, is an atypical antipsychotic medication widely prescribed for individuals grappling with mental health disorders such as schizophrenia and bipolar depression. This oral capsule is significant in the treatment landscape due to its efficacy in managing mood and thought disturbances. Its unique mechanism of action targets specific neurotransmitters in the brain,
0 Comments